TL;DRAbstract
This chapter describes the current state of India's health biotechnology sector and the factors enabling domestic companies to transition into global research and development-(R&D) based innovators. Historically, Indian companies entered this sector by developing cost-effective manufacturing processes and supplying existing products to local populations at more affordable prices. Such entry by national firms exerted a tremendous impact on both global and local companies. The entry of multiple Indian manufacturers into the vaccine sector increased competitive rivalry, drove down prices in the domestic market, and enabled Indian firms to begin supplying their products to global distributors such as the United Nations Children's Fund (UNICEF). As a result, today India is one of the largest suppliers of traditional vaccines worldwide.
Chat with Paper
AI Agents for this Paper
This chapter describes the current state of India's health biotechnology sector and the factors enabling domestic companies to transition into global research and development-(R&D) based innovators. Historically, Indian companies entered this sector by developing cost-effective manufacturing processes and supplying existing products to local populations at more affordable prices. Such entry by national firms exerted a tremendous impact on both global and local companies. The entry of multiple Indian manufacturers into the vaccine sector increased competitive rivalry, drove down prices in the domestic market, and enabled Indian firms to begin supplying their products to global distributors such as the United Nations Children's Fund (UNICEF). As a result, today India is one of the largest suppliers of traditional vaccines worldwide.
Keywords
Chat
Click to start Chat